These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25163684)

  • 1. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
    Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
    J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice.
    Shibata S; Gillespie JR; Kelley AM; Napuli AJ; Zhang Z; Kovzun KV; Pefley RM; Lam J; Zucker FH; Van Voorhis WC; Merritt EA; Hol WG; Verlinde CL; Fan E; Buckner FS
    Antimicrob Agents Chemother; 2011 May; 55(5):1982-9. PubMed ID: 21282428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced resistance to methionyl-tRNA synthetase inhibitors in Trypanosoma brucei is due to overexpression of the target.
    Ranade RM; Gillespie JR; Shibata S; Verlinde CL; Fan E; Hol WG; Buckner FS
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3021-8. PubMed ID: 23587950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors.
    Huang W; Zhang Z; Barros-Álvarez X; Koh CY; Ranade RM; Gillespie JR; Creason SA; Shibata S; Verlinde CLMJ; Hol WGJ; Buckner FS; Fan E
    Eur J Med Chem; 2016 Nov; 124():1081-1092. PubMed ID: 27788467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitors.
    Huang W; Zhang Z; Ranade RM; Gillespie JR; Barros-Álvarez X; Creason SA; Shibata S; Verlinde CLMJ; Hol WGJ; Buckner FS; Fan E
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2702-2707. PubMed ID: 28465105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
    Ojo KK; Ranade RM; Zhang Z; Dranow DM; Myers JB; Choi R; Nakazawa Hewitt S; Edwards TE; Davies DR; Lorimer D; Boyle SM; Barrett LK; Buckner FS; Fan E; Van Voorhis WC
    PLoS One; 2016; 11(8):e0160350. PubMed ID: 27500735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors.
    Zhang Z; Koh CY; Ranade RM; Shibata S; Gillespie JR; Hulverson MA; Huang W; Nguyen J; Pendem N; Gelb MH; Verlinde CL; Hol WG; Buckner FS; Fan E
    ACS Infect Dis; 2016 Jun; 2(6):399-404. PubMed ID: 27627628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
    Li Z; Xin W; Wang Q; Zhu M; Zhou H
    Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.
    Torrie LS; Brand S; Robinson DA; Ko EJ; Stojanovski L; Simeons FRC; Wyllie S; Thomas J; Ellis L; Osuna-Cabello M; Epemolu O; Nühs A; Riley J; MacLean L; Manthri S; Read KD; Gilbert IH; Fairlamb AH; De Rycker M
    ACS Infect Dis; 2017 Oct; 3(10):718-727. PubMed ID: 28967262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA Synthetase.
    Torrie LS; Robinson DA; Thomas MG; Hobrath JV; Shepherd SM; Post JM; Ko EJ; Ferreira RA; Mackenzie CJ; Wrobel K; Edwards DP; Gilbert IH; Gray DW; Fairlamb AH; De Rycker M
    ACS Infect Dis; 2020 May; 6(5):1044-1057. PubMed ID: 32275825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
    Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
    PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.
    Shibata S; Gillespie JR; Ranade RM; Koh CY; Kim JE; Laydbak JU; Zucker FH; Hol WG; Verlinde CL; Buckner FS; Fan E
    J Med Chem; 2012 Jul; 55(14):6342-51. PubMed ID: 22720744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness.
    Koh CY; Kim JE; Wetzel AB; de van der Schueren WJ; Shibata S; Ranade RM; Liu J; Zhang Z; Gillespie JR; Buckner FS; Verlinde CL; Fan E; Hol WG
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2775. PubMed ID: 24743796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.
    Kalidas S; Cestari I; Monnerat S; Li Q; Regmi S; Hasle N; Labaied M; Parsons M; Stuart K; Phillips MA
    Eukaryot Cell; 2014 Apr; 13(4):504-16. PubMed ID: 24562907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis.
    Devine WG; Diaz-Gonzalez R; Ceballos-Perez G; Rojas D; Satoh T; Tear W; Ranade RM; Barros-Álvarez X; Hol WG; Buckner FS; Navarro M; Pollastri MP
    ACS Infect Dis; 2017 Mar; 3(3):225-236. PubMed ID: 28110521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease.
    Kushwaha V; Capalash N
    Mol Biochem Parasitol; 2022 Sep; 251():111510. PubMed ID: 35988745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors.
    Xin W; Li Z; Wang Q; Du J; Zhu M; Zhou H
    Eur J Med Chem; 2020 Jan; 185():111827. PubMed ID: 31732256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.